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Abstract
Introduction:  Asthma  is  a  chronic  inﬂammatory  disease  with  multiple  phenotypes.  There  is  still
a major  gap  in  the  understanding  of  its  complex  causality.  Obstructive  sleep  apnea  (OSA)  is  a
common condition  that  has  been  implicated  as  a  risk  factor  for  asthma  exacerbations.
Objectives:  This  study  aims  to  characterize  patients  with  the  diagnosis  of  asthma  and  suspected
OSA; identify  the  presence  of  OSA  and  review,  on  the  current  literature,  the  association  between
asthma and  OSA,  as  an  overlap  syndrome.
Materials  and  methods:  The  authors  present  a  retrospective  study  that  included  patients  diag-
nosed with  asthma  that  underwent  sleep  study  in  a  3  year  period.  Demographic,  clinical  data,
body mass  index  (BMI),  sleep  study  parameters  and  treatments  were  analyzed.
Results: The  sample  consisted  of  47  patients.  The  majority  of  population  was  females  (68%)
and the  mean  age  was  55.65  ±  13.04  years.  The  most  common  nighttime  symptom  was  snoring
(93.6%). Regarding  BMI,  values  above  the  normal  limit  were  observed  in  89.36%  of  the  patients.
68% underwent  polysomnography  and  the  others  cardiorespiratory  polygraphy.  In  57.4%  of  the
patients, OSA  was  conﬁrmed  with  a  higher  prevalence  in  males  (73.3%)  compared  to  females
(50%). The  therapeutic  approach  in  81.8%  of  these  patients  was  home  ventilation  therapy.
Conclusion:  The  combination  of  asthma  and  OSA  has  become  increasingly  more  frequent.  In  the
described  study,  the  prevalence  of  OSA  was  57.4%,  value  that  is  in  fact  higher  than  in  general
population.  After  the  therapeutic  approach,  all  patients  referred  improvement  of  symptoms.
It is  therefore  essential  that  OSA  is  investigated  in  patients  with  asthma  when  there  is  poor
control of  symptoms,  in  order  to  achieve  a  better  control.
© 2015  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.∗ Corresponding author.
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Introduction
Asthma  is  a  chronic  inﬂammatory  disease  with  multiple
phenotypes  related  to  genetic  predisposition  and  various
environmental  interactions.  There  is  still  a  major  gap  in  the
understanding  of  its  complex  causality  and,  consequently,
in  the  primary  prevention  of  the  disease.1 Most  patients
with  asthma  have  mild-to-moderate  disease  that  can  be  eas-
ily  controlled  with  conventional  treatment.  However,  some
have  uncontrolled  asthma  despite  moderate  to  high  doses
of  inhaled  corticosteroids  and  long  acting  2  agonist  and/or
leukotriene  modiﬁer  combinations.  Factors  that  inﬂuence
asthma  control,  such  as  environmental  exposure,  comor-
bidities,  adherence,  and  inhalation  technique,  should  be
identiﬁed  and  adequately  addressed.2
Quality  of  sleep  in  patients  with  asthma  is  poorer,  com-
pared  to  those  with  chronic  obstructive  pulmonary  disease.
Whereas  some  comorbid  conditions,  such  as  rhinitis  and
gastroesophageal  reﬂux  disease  (GER),  are  well  recognized
to  aggravate  asthma,  little  is  known  about  the  potential
role  of  obstructive  sleep  apnea.3 OSA  is  characterized  by
episodes  of  complete  or  partial  upper  airway  obstruction
during  sleep.  It  is  known  that  it  induces  intermittent  hypox-
emia,  carbon  dioxide  retention  and  changes  in  hemodynamic
responses  during  sleep.
The  ﬁrst  study  examining  asthma  and  OSA  was  a  case
report  by  Hudgel  and  Shrucard,  in  1979.4 Since  then,  asthma
and  OSA  are  increasingly  troublesome  public  health  issues.
Mounting  evidence  implicates  OSA  as  a  risk  factor  for  asthma
exacerbations,5 therefore  it  is  imperative  to  look  further
into  the  connection  between  these  two  entities.
Objective
This  study  aims  to  characterize  the  patients  (demographic
analysis,  symptoms,  body  mass  index  (BMI))  admitted  in  a
Pulmonology  Department  with  the  diagnosis  of  asthma  and
suspected  OSA.  It  also  aims  to  review  the  existing  litera-
ture  on  a  possible  association  between  asthma  and  OSA,  as
an  overlap  syndrome  like  the  known  combination  ‘‘OSA  and
COPD’’.  Assess  the  effect  of  treatment  of  OSA  on  asthma
symptoms  was  also  an  objective  of  the  literature  review.
Materials and methods
The  authors  present  a  retrospective  study  carried  out  in  a
period  of  three  years  in  an  Immunoallergology  Department
which  included  patients  followed  in  an  outpatient  clinic  and
diagnosed  with  asthma.  During  this  period,  patients  diag-
nosed  with  asthma  underwent  a  structured  survey  during
the  consultation,  in  order  to  ascertain  symptoms  suggestive
of  OSA,  namely  symptoms  of  daytime  sleepiness,  snoring,
choking  or  gasping  during  sleep,  recurrent  awakenings,  unre-
freshed  sleep,  daytime  fatigue,  and  impaired  concentration.
All  patients  were  also  evaluated  using  the  Epworth  Sleepi-
ness  Scale.
The  patients  who  reported  characteristic  symptoms  of
OSA  underwent  overnight  sleep  study.  According  to  the
American  Association  of  Sleep  Medicine  2009  Guidelines,
the  patients  with  high  risk  of  OSA  underwent  cardiorespi-
ratory  study  in  the  absence  of  signiﬁcant  comorbidities.
t
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he  remaining  patients  underwent  polysomnography  study
PSG).  Patients  with  negative  cardiorespiratory  study  were
ubsequently  subjected  to  PSG  for  diagnostic  conﬁrmation.
Demographic  and  clinical  data,  BMI,  sleep  study  param-
ters  of  the  enrolled  patients  were  gathered  and  analyzed
sing  Microsoft  Ofﬁce  Excel  2007®.  Using  the  available  data,
 revision  of  the  current  literature  was  made,  and  MED-
INE  and  PubMed  databases  from  2000  to  the  present  were
earched  for  relevant  articles  regarding  the  association  of
SA  and  asthma  as  an  overlap  syndrome.  Particularly,  arti-
les  describing  pathophysiologic  conditions  occurring  in  OSA
hat  may  be  linked  to  asthma  pathogenesis  were  used  for
his  review,  as  well  as  articles  referring  to  the  therapeutic
pproach  in  these  patients.
esults
he  sample  consisted  of  47  patients  with  asthma  and  symp-
oms  suggestive  of  OSA,  with  female  predominance  (68%).
able  1  shows  some  demographic  and  clinical  characteris-
ics  of  the  patients  divided  into  two  groups:  patients  with
SA  and  without  OSA.  It  was  observed  that  patients  with
SA  were  older  than  those  without  OSA  (59  years  vs  48.7
ears),  fact  that  was  statistically  signiﬁcant  (p  =  0.0158  with
5%  conﬁdence  interval).  It  is  also  important  to  refer  that
egarding  BMI,  values  above  the  normal  limit  were  observed
n  42  (89.36%)  patients,  28  (87.5%)  females  and  14  (93.3%)
ales.  However,  in  both  groups,  similar  values  of  BMI  were
bserved.  In  the  group  with  OSA,  40.7%  were  overweight  and
5.6%  were  obese.  In  the  group  without  OSA,  35%  were  over-
eight  and  45%  were  obese.  In  this  group  it  was  registered
 higher  number  of  patients  with  normal  BMI  (3.7%  vs  20%).
All  the  evaluated  patients  reported  night  symptoms,
he  most  common  was  snoring  (93.6%)  and  no  differences
ere  registered  between  the  two  groups.  The  patients  also
eferred  choking  or  gasping  during  sleep  (57.4%),  exces-
ive  daytime  sleepiness  (EDS)  (36.2%),  morning  headaches
29.8%)  and  unrefreshing  sleep  (19.1%).  Concerning  the
pworth  Sleepiness  Scale,  22  (46.81%)  patients  had  a  score
igher  than  10  and  the  mean  value  was  11.
In  terms  of  the  medication  use,  21.3%  of  the  patients  only
ecurred  to  quick  relief  medication,  such  as  short-acting
nhaled  beta-agonists.  Most  patients  (53.2%)  presented  with
ymptoms  of  controlled  asthma,  under  ﬁxed  inhaled  asso-
iation  between  long-acting  beta-agonists  and  low-dose
nhaled  corticosteroids.  19.1%  of  the  patients,  needed  the
ssociation  of  a leukotriene  modiﬁer,  as  well  as  medium  or
igh-dose  of  inhaled  corticosteroids.  And  ﬁnally  the  most
ymptomatic  patients  (6.4%)  were  under  oral  corticoste-
oids.
Regarding  the  lung  function  testes,  spirometry  revealed
alues  within  the  normal  range  in  69%  of  the  patients.  In  the
emaining  patients,  an  obstructive  pattern  was  detected,
ccording  to  the  values  of  the  FEV1/CVF  ratio.  The  mean
alue  of  this  parameter  was  77.8%  (±12.5%).  The  values  of
EV1  varied  between  35.1%  and  127.8%,  the  mean  value  was
5%  (±22.7%).  The  obstruction  was  considered  mild  in  8%  of
he  patients,  moderate  in  10%  and  severe  in  5%.  CPT  was
ormal  in  all  patient,  as  expected.  DLCO  was  determined
nly  in  36%  of  the  patients,  and  in  all  cases  the  value  was
ithin  normal  range.
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Table  1  Demographic  and  physiologic  characteristics,  smoking  history  and  comorbidities  of  the  enrolled  patients.
Characteristics  Total  Patients  with  OSA  Patients  without  OSA
N  (%)  47  (100)  27  (100)  20  (100)
Age, years  (mean  ±  SD)  55.65  ±  13.04  59  ±  12.44  48.7  ±  11.13
Female, n  (%)  32  (68)  16  (59.2)  16  (80)
BMI, kg/m2 (mean  ±  SD)
Normal  weight  (BMI  =  20--24.99),  n  (%)
Overweight  (BMI  =  25--29.99),  n  (%)
Obese  (BMI  ≥  30),  n  (%)
31.36  ±  5.33
5  (10.6)
18  (38.3)
24  (51.1)
31.42  ±  5.05
1  (3.7)
11  (40.7)
15 (55.6)
31.04  ±  5.08
4  (20)
7 (35)
9 (45)
Habitual snoring,  n  (%) 44  (93.6) 25  (92.6) 19  (90)
Epworth Sleepiness  Scale  (mean  ±  SD)  11  (6)  11  (6.2)  11  (6.6)
Rhinitis associated  with  asthma,  n  (%)  33  (70.2)  17  (63)  16  (80)
Comorbidities
Cardiovascular  disease,  n  (%)
Depressive  disorder,  n  (%)
Thyroid  disorders,  n  (%)
Fibromyalgia,  n  (%)
Gastroesophageal  reﬂux  disease,  n  (%)
14  (29.8)
15  (32)
7 (14.9)
6 (12.8)
4 (8.5)
10  (37)
5 (18.5)
5 (18.5)
1 (3.7)
3 (11.1)
4  (20)
10  (50)
2 (10)
5 (25)
1 (5)
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Of  the  47  patients,  32  (68%)  underwent  overnight  PSG
nd  15  (32%)  cardiorespiratory  polygraphy.  In  27  (57.4%)
atients  it  was  diagnosed  OSA,  with  higher  prevalence  in
ales  (73.3%)  compared  to  females  (50%).  The  results  of  the
leep  studies  are  shown  in  Table  2.  As  expected,  the  Apnea
ypopnea  Index  (AHI)  was  higher  in  the  group  of  patients
ith  OSA.  The  percentage  of  patients  with  mild  or  moderate
SA  was  similar  and  only  2  patients  presented  an  AHI  >  30.
he  other  results,  expectedly,  revealed  lower  mean  and  min-
mum  oxygen  saturation  during  sleep  in  the  group  of  patients
ith  OSA,  and  higher  oxygen  desaturation  index.
The  therapeutic  approach  in  most  patients  consisted
n  general  sleep  hygiene  measures,  such  as  weight  loss,
voidance  of  alcohol  for  4--6  h  prior  to  bedtime,  positional
herapies,  regular  hours  of  sleep  and  optimal  treatment  of
sthma  and  rhinitis.  Despite  these  measures,  22  patients
nitiated  positive  airway  pressure  therapy,  21  patients
ith  continuous  or  automatic  positive  airway  pressure
CPAP/APAP)  and  one  patient  with  bilevel  positive  airway
ressure  (BPAP).  These  patients  had  severe,  moderate  or
ild  OSA  with  associated  comorbidities  or  were  quite  symp-
omatic.
Clinical  follow-up  was  performed  3  and  6  months  after
he  beginning  of  the  therapeutic  measures.  Interestingly,  all
o
w
o
Table  2  Diagnostic  sleep  study  results  of  the  enrolled  patients.
Characteristics  Total  
Apnea/hypopnea  index,  (mean  ±  SD)
n (%)
Mild
Moderate
Severe
17.55  
13  (27
12 (25
2 (4.3
Mean oxygen  saturation  during  sleep,  (mean  ±  SD)  93.8  ±
Minimum oxygen  saturation  during  sleep,  (mean  ±  SD)  81  ±  1
Oxygen desaturation  index  (n/h),  (mean  ±  SD)  12.5  ±2 (7.4) 2 (10)
he  patients,  in  both  groups,  reported  improvement  of  the
ymptoms,  especially  in  the  nighttime  complaints.  They  also
eferred  improvement  in  quality  of  sleep,  less  use  of  reliever
edications,  fewer  exacerbation  episodes,  and  improve-
ent  in  neuro-cognitive  complaints.
iscussion
t  is  known  that  asthma  symptoms  tend  to  be  more  severe
t  night  and  that  asthma-related  deaths  are  most  likely  to
ccur  during  the  night  or  early  morning.  Nocturnal  symp-
oms  occur  in  60--74%  of  asthma  patients  and  are  markers
f  inadequate  control  of  the  disease.4 The  mechanisms  by
hich  nocturnal  asthma  develops  remain  unclear  and  may
ary  from  patient  to  patient.6 The  results  of  our  study  con-
rm  this  fact  and  show  the  presence  of  nocturnal  symptoms
n  all  patients,  whether  they  were  diagnosed  with  OSA  or
ot.  In  fact,  90%  of  patients  without  OSA  reported  frequent
noring  complaints.In this  study,  sleep  studies  showed  that  the  prevalence
f  OSA  in  the  group  of  investigated  patients  was  57.4%,
hich  is  consistent  with  already  known  fact  that  symptoms
f  sleep-disordered  breathing,  especially  OSA,  are  common
Patients  with  OSA  Patients  without  OSA
±  26.5
.7)
.5)
)
29.57  ±  29.8
13  (48.1)
12 (44.4)
2 (7.8)
1.33  ±  1.48
0
0
0
 3  92.6  ±  3  95.4  ±  2
1.7  74.2  ±  10.6  91  ±  5
 18.1  20  ±  21  2.4  ±  2.2
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in  asthmatic  patients  and  are  associated  with  asthma  sever-
ity.  Teodorescu  et  al.7 found  that  in  a  population-based
prospective  epidemiologic  study  beginning  in  1988,  asthma
was  associated  with  an  increased  risk  of  new-onset  OSA.  In
this  study,  22  of  81  participants  (27%)  with  asthma  experi-
enced  incident  OSA  over  their  ﬁrst  observed  4-year  follow-up
interval  compared  with  75  of  466  participants  (16%)  without
asthma.
Byun  et  al.8 selected  167  adults  with  the  following  com-
plaints:  habitual  snoring,  EDS,  choking  during  sleep,  sleep
fragmentation,  nonrestorative  sleep,  daytime  fatigue  and
difﬁculty  concentrating.  Those  patients  were  referred  for
clinical  evaluation  and  ApneaLink,  and  only  32  were  assessed
by  full  PSG.  The  prevalence  of  OSA  depended  on  AHI  cut-
off  values;  AHI  values  of  ≥5/h,  ≥10/h,  ≥15/h  and  ≥30/h
corresponded  to  111  (66%),  71  (42.5%),  52  (31%)  and  20
(12%)  patients,  respectively.  Of  the  patients  who  had  an
AHI  >  5  events/h,  37  (33.6%)  had  been  diagnosed  with  mod-
erate  to  severe  asthma.  They  concluded  that  moderate
to  severe  asthma  showed  strong  correlations  with  OSA  in
addition  to  the  well-known  predictors  of  age  and  male
gender.
In  patients  with  asthma,  OSA  acts  as  a  mechanism  that
contributes  to  the  lack  of  asthma  control,9 because  the
reduction  in  airway  caliber  in  nocturnal  asthma  is  often  asso-
ciated  with  sleep  fragmentation,  early  morning  awakening,
difﬁculty  maintaining  sleep,  and  EDS.  Increased  abdominal
pressure  during  periods  of  OSA  contributes  to  GER,  bronchial
hyperreactivity,  and  bronchial  inﬂammation.  Patients  with
difﬁcult-to-control  asthma  can  have  an  increase  of
the  number  of  respiratory  events  and  oxyhemoglobin
desaturation,  especially  during  rapid  eye  movement
sleep.4
Julien  et  al.10 tested  the  hypothesis  that  the  preva-
lence  and  severity  of  OSA  is  greater  among  patients  with
severe  compared  to  those  with  moderate  asthma  and  con-
trols  without  asthma.  In  this  study,  OSA  was  present  in  23
of  26  (88%)  patients  with  severe  asthma,  15  of  26  (58%)
patients  with  moderate  asthma,  and  8  of  26  (31%)  controls
without  asthma.  It  was  also  veriﬁed  that  greater  asthma
severity  translated  to  a  higher  value  of  AHI;  in  his  study,  it
was  reported  that  patients  with  severe  asthma  had  a  mean
AHI  value  of  23.6  events/h,  those  with  moderate  asthma
had  an  AHI  of  19.5  events/h,  and  those  with  mild  asthma
had  an  AHI  of  9.9  events/h  (p  <  0.001).  Mean  nocturnal  oxy-
gen  saturation  was  signiﬁcantly  lower  in  the  patients  with
severe  asthma  than  in  the  controls.  This  is  also  reported
in  our  study,  where  mean  oxygen  saturation  during  sleep  in
patients  with  OSA  was  92.6%  vs  95.4%  in  the  patients  with-
out  OSA.  The  high  prevalence  of  OSA  in  patients  with  severe
asthma  suggests  that  recognition  and  treatment  of  OSA  plays
an  important  role  in  improving  asthma  control.10 Teodorescu
et  al.11 also  found  that  asthma  patients  who  were  using  low-
dose  inhaled  corticosteroids  regularly,  those  who  were  using
medium-dose  inhaled  corticosteroids  regularly,  and  those
who  were  using  high-dose  inhaled  corticosteroids  regularly
were,  respectively,  2.29  times,  3.67  times,  and  5.43  times
as  likely  to  develop  OSA  as  were  those  who  were  not  using
inhaled  corticosteroids.
There  are  several  hypotheses  that  can  explain  the  inter-
action  between  OSA  and  asthma.  Obesity  is  considered  one
of  the  causal  factors  for  OSA.  It  has  been  suggested  that,
t
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eyond  a  certain  threshold  of  obesity,  metabolic  factors
ecome  involved  in  the  pathophysiology  of  upper  airway
nﬂammation,  as  well  as  in  bronchial  hyperreactivity,  inter-
ering  with  the  clinical  manifestations  of  asthma.12 In  the
nited  States  it  is  estimated  that  obesity  may  be  respon-
ible  for  the  development  of  250,000  new  cases  of  asthma
er  year13 and  it  seems  that  the  association  between  asthma
nd  OSA  worsens  the  clinical  picture  of  asthma,  given  that
SA  can  stimulate  weight  gain.  It  is  known  that  OSA  inter-
eres  with  lipid  homeostasis  and  systemic  inﬂammation  and,
hen  associated  with  obesity,  affects  glycemic  regulation,
nterfering  with  insulin  sensitivity,  independently  of  the
MI.4
Peppard  et  al.14 evaluated  adults  at  two  different  time
oints  (at  baseline  and  4  years  later).  Initial  data  showed
hat  individuals  with  BMI  ≥  30  kg/m2 (n  =  268)  had  an  AHI  of
.4  events/h;  those  with  30  <  BMI  ≥  25  kg/m2 (n  =  241)  had  an
HI  of  2.6  events/h;  and  those  with  BMI  <  25  kg/m2 (n  =  181)
ad  an  AHI  of  1.2  events/h.  The  authors  found  that  increase
n  weight  was  positively  correlated  with  the  AHI;  that  is,
atients  who  gain  10%  of  their  body  weight  tend  to  show  an
ncrease  of  approximately  32%  in  the  AHI,  and  a  10%  reduc-
ion  in  weight  resulted  in  a  26%  reduction  in  the  AHI.  In
ur  sample,  values  above  the  normal  limit  of  the  BMI  were
bserved  in  42  (89.36%)  patients,  28  (87.5%)  females  and
4  (93.3%)  males.  In  the  group  of  patients  with  OSA,  those
atients  with  BMI  ≥  30  kg/m2 (n  =  15)  had  a  mean  AHI  of  32.94
vents/h;  those  with  30  <  BMI  ≥  25  kg/m2 (n  =  11)  had  a  mean
HI  of  20.53  events/h;  and  the  one  with  BMI  <  25  kg/m2 had
n  AHI  of  6.1  events/h.
Another  hypothesis  refers  to  the  relationship  between
SA,  asthma  and  systemic  inﬂammation.  It  is  known  that  OSA
romotes  inﬂammatory  responses,  which  is  demonstrated
y  a reversible  increase  in  C-reactive  protein  (CPR).  Gozal
t  al.15 noted  that  serum  levels  of  CRP  decreased  propor-
ionally  to  the  AHI,  the  reduction  being  more  signiﬁcant
n  a  group  of  nonobese  children.  OSA  can  cause  or  aggra-
ate  proinﬂammatory  states  through  effects  on  sympathetic
yperreactivity,  oxidative  stress,  or  both.16
It  is  also  believed  that  the  signiﬁcant  increase  in  negative
ntrathoracic  pressure  caused  by  upper  airway  obstruction
an  predispose  to  retrograde  movement  of  gastric  contents.
ne  study  showed  that  71.4%  of  patients  with  OSA  had  GER
as  measured  by  pH  monitoring);  of  those,  10.4%  reported
o  symptoms.4 It  has  been  reported  that  OSA-induced  GER
an  play  an  important  role  in  asthma  symptoms.  However,
his  association  is  not  yet  fully  demonstrated.  Dixon  et  al.13
oncluded  GER  was  not  associated  with  any  measure  of
sthma  severity.  Of  common  comorbidities,  OSA  but  not  GER
ay  contribute  to  poor  asthma  control.  In  our  sample,  the
revalence  of  GER  in  the  population  with  OSA  was  of  11.1%.
owever,  no  statistically  signiﬁcant  relationship  was  estab-
ish  with  the  control  of  asthma  or  the  severity  of  OSA,  due
o  the  small  number  of  patients.
Appropriate  and  adequate  medical  treatment  should  be
he  ﬁrst  step  for  asthmatic  patients  with  nighttime  symp-
oms.  But  they  may  continue  in  some  patients,  against
ptimal  medical  treatment.  In  this  condition,  other  fac-
ors  responsible  for  the  symptoms  should  be  investigated.
iftci  et  al.17 showed  the  improvement  of  nocturnal  asthma
ymptoms  with  CPAP.  In  this  study,  2  months  of  CPAP  treat-
ent  improved  signiﬁcantly  nighttime  symptoms.  These
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10  
ndings  suggest  that  OSA  might  be  the  responsible.  Alkhalil
t  al.5 describe  potential  mechanisms  whereby  CPAP,  the
rst  line  of  therapy  for  OSA,  might  modify  airway  smooth
uscle  function  and  asthma  control  in  patients  with  both
isorders.  They  concluded  that  use  of  CPAP  can  decrease
xacerbations,  improve  quality  of  life,  and  reduce  the
umber  of  cases  of  difﬁcult-to-control  asthma.  In  our  sam-
le,  22  patients  initiated  positive  airway  pressure  and
eported  improvement  of  the  nighttime  symptoms.  The
emaining  patients  also  reported  symptomatic  improve-
ent  in  response  to  the  measures  implemented  and
ubsequently  reinforced  during  follow-up.  These  included
ptimal  control  of  asthma  and  rhinitis,  and  the  usual
leep  hygiene  measures  for  snoring,  referred  above.  Despite
he  ever-increasing  population  of  patients  with  both  dis-
rders,  large,  prospective,  randomized  controlled  studies
re  necessary  to  more  fully  evaluate  CPAP  and  asthma
utcomes.17
In  conclusion,  although  the  association  between  OSA  and
sthma  is  common,  it  is  poorly  investigated.  If  untreated,
SA  can  contribute  to  the  lack  of  control  of  asthma,
specially  nocturnal  asthma  symptoms.  It  is  important  to
valuate  the  presence  of  symptoms  of  OSA  in  patients  pre-
enting  with  nocturnal  asthma,  because  treatment  with
PAP  may  lead  to  a  substantial  clinical  improvement.  Snor-
ng  in  patients  with  asthma  raise  clinical  suspicion  of  OSA.
owever,  EDS  resulting  from  nocturnal  asthma  symptoms  is
lso  an  important  sign  of  OSA.
In  our  study,  there  was  no  difference  in  symptoms  of
DS  and  snoring  in  the  two  groups,  therefore,  the  critical
ymptoms  of  OSA  were  not  enough  to  predict  the  diagnosis
n  these  patients.  Given  the  high  prevalence  of  OSA  in  the
sthma  population,  it  is  important  to  reinforce  that  sleep
tudies  should  be  used  to  document  OSA  and  are  helpful  in
rescribing  proper  treatment  to  achieve  a  better  control  of
he  disease.
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